Ado-trastuzumab emtansine injection is used to treat breast cancer that has spread to other parts of the body and has not improved or worsened despite treatment with other medications. Ado-trastuzumab emtansine is also used after surgery for a specific type of breast cancer in women who have been treated with other chemotherapy drugs prior to surgery but whose surgically removed tissue still contains cancer cells. Ado-trastuzumab emtansine belongs to the category of drugs known as antibody-drug conjugates. It functions by eliminating cancer cells.
Ado-trastuzumab emtansine injection is a powder that must be mixed with liquid and infused (slowly injected) into a vein by a physician or nurse in a hospital or other medical facility. Typically, it is injected every three weeks. The duration of your treatment depends on how well your body responds to the medication and how severe the side effects are.
Ado-trastuzumab emtansine injection may cause severe reactions related to infusion, which may occur during or shortly after the infusion. You should receive your first dose of ado-trastuzumab emtansine within 90 minutes. A physician or nurse will closely monitor your response to this medication. If you do not experience any serious complications when receiving your first dose of ado-trastuzumab emtansine, it will typically take 30 minutes to administer each of your subsequent doses. Inform your doctor immediately if you experience any of the following symptoms: flushing, fever, chills, dizziness, lightheadedness, fainting, shortness of breath, difficulty breathing, or a rapid, irregular, or pounding heartbeat.
If you experience certain side effects, your doctor may need to delay your treatment, slow down the infusion, or discontinue your treatment. During your treatment with ado-trastuzumab emtansine, be sure to let your physician know how you feel.
Ado-trastuzumab emtansine may cause other side effects. Call your doctor if you have any unusual problems while receiving this medication.
Privacy Overview